MHT shortages forcing patients to ration patches, warns leading GP
Shortages of multiple oestrogen patches have been extended due to manufacturing issues.
Shortages of oestrogen patches continue to “frustrate” doctors prescribing menopausal hormone therapy, according to a leading GP who says many patients have been forced to ration patches or switch to gels.
All strengths of transdermal oestradiol (Estradot) patches will be unavailable until mid-2024, while three strengths of combined oestradiol/norethisterone acetate (Estalis) patches will be in short supply for at least another month.
